F
Felicia Cosman
Researcher at Columbia University
Publications - 203
Citations - 23687
Felicia Cosman is an academic researcher from Columbia University. The author has contributed to research in topics: Osteoporosis & Bone density. The author has an hindex of 63, co-authored 196 publications receiving 21048 citations. Previous affiliations of Felicia Cosman include New York State Department of Health & York University.
Papers
More filters
Journal ArticleDOI
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Felicia Cosman,S. J. de Beur,Meryl S. LeBoff,E. M. Lewiecki,B. Tanner,S. Randall,Robert Lindsay +6 more
TL;DR: The Clinician’s Guide to Prevention and Treatment of Osteoporosis was developed by an expert committee of the National Osteiporosis Foundation in collaboration with a multispecialty council of medical experts in the field of bone health convened by NOF.
Journal ArticleDOI
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black,Pierre D. Delmas,Richard Eastell,Ian R. Reid,Steven Boonen,Jane A. Cauley,Felicia Cosman,Peter L. Lakatos,Ping Chung Leung,Z. Man,Carlos Mautalen,Peter Mesenbrink,Huilin Hu,John Caminis,Karen Tong,Theresa Rosario-Jansen,Joel S. Krasnow,Trisha F. Hue,Deborah E. Sellmeyer,Erik Fink Eriksen,Steven R. Cummings +20 more
TL;DR: Treatment with zoledronic acid reduced the risk of morphometric vertebral fracture by 70% during a 3-year period, as compared with placebo.
Journal ArticleDOI
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
Elizabeth Shane,David B. Burr,Peter R. Ebeling,Bo Abrahamsen,Robert A. Adler,Thomas D. Brown,Angela M. Cheung,Felicia Cosman,Jeffrey R. Curtis,Richard M. Dell,David W. Dempster,Thomas A. Einhorn,Harry K. Genant,Piet Geusens,Klaus Klaushofer,Kenneth J. Koval,Joseph M. Lane,Fergus McKiernan,Ross E. McKinney,Alvin Choong Meng Ng,Jeri W. Nieves,Regis J. O'Keefe,Socrates E. Papapoulos,Howe Tet Sen,Marjolein C. H. van der Meulen,Robert S. Weinstein,Michael P. Whyte +26 more
TL;DR: This newer evidence suggests that AFFs are stress or insufficiency fractures, and studies with radiographic review consistently report significant associations between A FFs and BP use, although the strength and magnitude of effect vary.
Journal ArticleDOI
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
Felicia Cosman,Daria B. Crittenden,Jonathan D. Adachi,Neil Binkley,Edward Czerwiński,Serge Ferrari,Lorenz C. Hofbauer,E. Lau,E. M. Lewiecki,Akimitsu Miyauchi,C. A. F. Zerbini,C. E. Milmont,L. Chen,Judy Maddox,Paul D Meisner,Cesar Libanati,Andreas Grauer +16 more
TL;DR: In postmenopausal women with osteoporosis, romosozumab was associated with a lower risk of vertebral fracture than placebo at 12 months and, after the transition to denosumab, at 24 months.
Journal ArticleDOI
The 2017 hormone therapy position statement of The North American Menopause Society.
JoAnn V. Pinkerton,Fernando Sánchez Aguirre,Jennifer Blake,Felicia Cosman,Howard N. Hodis,Susan Hoffstetter,Andrew M. Kaunitz,Sheryl A. Kingsberg,Pauline M. Maki,JoAnn E. Manson,Polly Marchbanks,Michael R. McClung,Lila E. Nachtigall,Lawrence M. Nelson,Diane Todd Pace,Robert L. Reid,Phillip M. Sarrel,Jan L. Shifren,Cynthia A. Stuenkel,Wulf H. Utian +19 more
TL;DR: Hormone therapy (HT) remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause (GSM) and has been shown to prevent bone loss and fracture.